Pediatric Moyamoya Disease in Nepal and Challenges in a Resource-Limited Setting: A Case Report

Kapil Khanal1, Sunil Dhungana2, Bindu Gyawali2

  • 1Maharajgunj Medical Campus (MMC), Institute of Medicine (IOM) Tribhuvan University (TU) Kathmandu Nepal.

Clinical Case Reports
|October 9, 2025
PubMed

Insights

Moyamoya disease (MMD), a rare cerebrovascular disorder, was diagnosed in a Nepali child presenting with stroke-like symptoms. Conservative management provided partial recovery, highlighting MMD

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Vascular Neurology

Background:

  • Moyamoya disease (MMD) is a rare, progressive cerebrovascular disorder.
  • Characterized by internal carotid artery stenosis and fragile collateral vessels.
  • Underreported in Nepal, though common in East Asia; pediatric cases present with ischemic symptoms.

Purpose of the Study:

  • To report a pediatric case of Moyamoya disease in Nepal.
  • To highlight diagnostic and management considerations in a resource-limited setting.

Main Methods:

  • Case report of a 7-year-old boy with fever, seizures, and hemiparesis.
  • Diagnostic workup included MRI and MR angiography.
  • Conservative management with aspirin and levetiracetam was initiated.

Main Results:

  • MRI/MRA confirmed Moyamoya disease with multiple infarcts and carotid stenosis.
  • Cerebrospinal fluid and autoimmune markers were unremarkable.
  • The patient showed partial recovery with conservative treatment; surgery was deferred.

Conclusions:

  • Moyamoya disease should be considered in pediatric stroke cases, even in non-endemic regions.
  • Conservative management can offer symptomatic relief in resource-limited settings like Nepal.
  • Long-term follow-up is crucial for monitoring disease progression and surgical needs.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
246
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
212
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
460
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
338
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
289